Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?

To: Ford Investor who wrote (345)	12/18/1997 3:13:00 PM
From: aknahow	Respond to of 442

If you like SMTG sell Jan puts @$5. Just did a few for 5/8. Down side is that if there is a big recovery and SMTG just goes up you never end up with a position. But if there is something wrong with the co you wil own it at $5. However the return for a bit over one month sort of compensates for not owning the stock in case it is not put to you. Appreciated you post because even though I follow the stock and see its price and had tried to do same puts previously at 3/8 I had not checked the put quotes. Your post got me to do so.

To: Ford Investor who wrote (345)	12/18/1997 11:46:00 PM
From: Bharat H. Barai	Read Replies (2) \| Respond to of 442

Dear Steve, Somatogen is an orphan stock. The performance is very disheartening. The stokcs are priced on who wants to buy or sell. Clearly it is very disappointing for people like me and others who have followed the science, not market. This sell off is most probably related to tax selling. Until the company comes up with some positive news, I doubt the stock will perk up. The stocks move on news or earnings. Neither is happening here. Stock fundamentals are unchanged. Bharat H. Barai MD